Correlation Between Ocugen and Effector Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ocugen and Effector Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocugen and Effector Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocugen Inc and Effector Therapeutics, you can compare the effects of market volatilities on Ocugen and Effector Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocugen with a short position of Effector Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocugen and Effector Therapeutics.
Diversification Opportunities for Ocugen and Effector Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Ocugen and Effector is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ocugen Inc and Effector Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Effector Therapeutics and Ocugen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocugen Inc are associated (or correlated) with Effector Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Effector Therapeutics has no effect on the direction of Ocugen i.e., Ocugen and Effector Therapeutics go up and down completely randomly.
Pair Corralation between Ocugen and Effector Therapeutics
If you would invest 81.00 in Ocugen Inc on December 29, 2024 and sell it today you would lose (1.00) from holding Ocugen Inc or give up 1.23% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Ocugen Inc vs. Effector Therapeutics
Performance |
Timeline |
Ocugen Inc |
Effector Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Ocugen and Effector Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ocugen and Effector Therapeutics
The main advantage of trading using opposite Ocugen and Effector Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocugen position performs unexpectedly, Effector Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Effector Therapeutics will offset losses from the drop in Effector Therapeutics' long position.Ocugen vs. Vaxart Inc | Ocugen vs. Novavax | Ocugen vs. Rain Enhancement Technologies | Ocugen vs. Ocean Biomedical |
Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |